Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia
1995 ◽
Vol 22
(s1)
◽
pp. S316-S317
◽
2008 ◽
Vol 44
(2)
◽
pp. 446-447
1989 ◽
Vol 3
(2)
◽
pp. 219-227
◽
2007 ◽
Vol 52
(1)
◽
pp. 136-145
◽
Keyword(s):